An Epigenetic Role of Mitochondria in Cancer

Cells. 2022 Aug 13;11(16):2518. doi: 10.3390/cells11162518.

Abstract

Mitochondria are not only the main energy supplier but are also the cell metabolic center regulating multiple key metaborates that play pivotal roles in epigenetics regulation. These metabolites include acetyl-CoA, α-ketoglutarate (α-KG), S-adenosyl methionine (SAM), NAD+, and O-linked beta-N-acetylglucosamine (O-GlcNAc), which are the main substrates for DNA methylation and histone post-translation modifications, essential for gene transcriptional regulation and cell fate determination. Tumorigenesis is attributed to many factors, including gene mutations and tumor microenvironment. Mitochondria and epigenetics play essential roles in tumor initiation, evolution, metastasis, and recurrence. Targeting mitochondrial metabolism and epigenetics are promising therapeutic strategies for tumor treatment. In this review, we summarize the roles of mitochondria in key metabolites required for epigenetics modification and in cell fate regulation and discuss the current strategy in cancer therapies via targeting epigenetic modifiers and related enzymes in metabolic regulation. This review is an important contribution to the understanding of the current metabolic-epigenetic-tumorigenesis concept.

Keywords: cancer; epigenetics; metabolism; mitochondria.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Carcinogenesis / genetics
  • Carcinogenesis / metabolism
  • Epigenesis, Genetic*
  • Histones / metabolism
  • Humans
  • Mitochondria / genetics
  • Mitochondria / metabolism
  • Neoplasms* / genetics
  • Neoplasms* / metabolism
  • Tumor Microenvironment

Substances

  • Histones

Grants and funding

Funding for this project includes the National Natural Science Foundation of China (81872072, J.C.), (82073274, Y.S.), and the Science Technology Commission of Shanghai Municipality (20S11900700, Y.S.).